Last update 17 Jul 2025

WO2023241640

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
DUBs x USP25 x USP28 x USPs
Action
inhibitors
Mechanism
DUBs inhibitors(Deubiquinating enzymes inhibitors), USP25 inhibitors(ubiquitin specific peptidase 25 inhibitors), USP28 inhibitors(ubiquitin specific peptidase 28 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesNervous System Diseases+ [1]
Active Indication
Autoimmune DiseasesInflammationNeoplasms+ [1]
Inactive Indication-
Originator Organization
Shenzhen Bay LaboratoryPeking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate School
Active Organization
Peking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate SchoolShenzhen Bay Laboratory
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2023241640
Login to view more data
100 Translational Medicine associated with WO2023241640
Login to view more data
100 Patents (Medical) associated with WO2023241640
Login to view more data
100 Deals associated with WO2023241640
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesDiscovery-
Shenzhen Bay Laboratory
21 Dec 2023
Autoimmune DiseasesDiscovery-
Peking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate School
21 Dec 2023
InflammationDiscovery-
Shenzhen Bay Laboratory
21 Dec 2023
InflammationDiscovery-
Peking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate School
21 Dec 2023
NeoplasmsDiscovery-
Shenzhen Bay Laboratory
21 Dec 2023
NeoplasmsDiscovery-
Peking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate School
21 Dec 2023
Neurodegenerative DiseasesDiscovery-
Shenzhen Bay Laboratory
21 Dec 2023
Neurodegenerative DiseasesDiscovery-
Peking University Shenzhen Graduate SchoolPeking University Shenzhen Graduate School
21 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free